Episode

First Keto RCT for Serious Mental Illness: Hear from the Study Authors

Podcast
Metabolic Mind
Published
Aug 16, 2026
Duration seconds
1704
Processing state
not_requested
Canonical source
https://metabolicmind.org/
Audio
https://episodes.captivate.fm/episode/1886ee43-1c5f-4f41-8f8a-ff62dd34c47a.mp3
JSON
/v1/public/podcasts/metabolic-mind-6253550/episodes/first-keto-rct-for-serious-mental-illness-hear-from-the-study-authors
Markdown
/podcast/metabolic-mind-6253550/first-keto-rct-for-serious-mental-illness-hear-from-the-study-authors.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/metabolic-mind-6253550/episodes/first-keto-rct-for-serious-mental-illness-hear-from-the-study-authors/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/metabolic-mind-6253550/first-keto-rct-for-serious-mental-illness-hear-from-the-study-authors.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Can ketogenic therapy improve symptoms, cognition, and metabolic health in people living with serious mental illness? In this episode of Metabolic Mind, Dr. Bret Scher speaks with Dr. Judy Ford, Juliette Kyner (previously Juliette Ward), and Dr. Shebani Sethi about the first-ever randomized controlled trial of a ketogenic diet intervention in individuals living with schizophrenia spectrum disorder or bipolar I disorder with psychotic features. The conversation explores what made this trial possible, from prepared meals and coaching to the structured support that helped participants stay engaged. It also highlights encouraging four-month findings across metabolic health, cognition, depressive symptoms, and both positive and negative psychiatric symptoms. They discuss: Why this trial is an important step for metabolic psychiatry How participants adhered to a ketogenic diet with structured support What changed in metabolic health markers like BMI, A1C, and HOMA-IR Why cognitive improvements were especially meaningful How positive symptoms, negative symptoms, and depressive symptoms changed over time What family members noticed as participants re-engaged with daily life Why future studies may need to be longer, larger, and more mechanistic This trial marks an important step for metabolic psychiatry and points to the need for larger, longer, fully controlled studies that can better clarify how ketogenic interventions may affect metabolic, cognitive, and psychiatric outcomes. 👉 Learn more about this trial on our study page: First-Ever Randomized Controlled Trial of Ketogenic Diet in Schizophrenia-Spectrum and Bipolar I Disorder 🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic…